Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure

NCT: NCT04475393 · ACTIVE_NOT_RECRUITING

NCT IDNCT04475393
StatusACTIVE_NOT_RECRUITING
Start Date2022-12-12
Completion2027-04

Brief Summary

The objective of this clinical investigation is to evaluate the efficacy and the safety of the Carmat Total Artificial Heart for the treatment of refractory advanced heart failure in transplant eligible patients.

Frequently Asked Questions

What is Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure?

Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure is a clinical trial registered under NCT04475393. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04475393?

The current status of NCT04475393 (Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure) is: ACTIVE_NOT_RECRUITING.

When did Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure start?

Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure started on 2022-12-12.

Related Devices

PMA P030011 Artificial heart Syncardia Systems, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑